Sequential study of antigen persistence and concomitant inflammatory reactions relative to side-effects and growth of Atlantic salmon (Salmo salar L.) following intraperitoneal injection with oil-adjuvanted vaccines
Introduction
Vaccination of Atlantic salmon (Salmo salar L.) against furunculosis and cold-water vibriosis with oil-adjuvanted vaccines induces long-lasting protective immunity [1], [2]. Intraperitoneal (i.p.) injection of oil-based vaccines, however, results in the formation of visible injection-site lesions that may persist up to harvest size. This may on some occasions result in downgrading of fish at slaughter or after processing. The intra-abdominal lesions are recognised grossly as melaninisation and adhesions between internal organs or between the organs and the peritoneal wall [2], [3], [4].
Side-effects should be kept at a minimum and are in principle not acceptable because they can lead to reduced growth rate, downgrading of fish and may also be associated with fish suffering. Although the mechanisms are not known, it is not unlikely that specific components in the vaccines, the vaccine formulation and the inflammatory cell profile or any combination thereof, may contribute to the development and maintenance of side-effects.
In Atlantic salmon, side-effects following i.p. injection of oil-adjuvanted vaccines have been characterised by several authors [2], [5] who focused on the duration and severity of lesions. However, there are very few reports that address the effects of persistent/retained antigens at the injection site besides Press et al. [6] whose emphasis was on protection conferred by vaccines administered through different routes. Persistent antigens at the injection site, while important in the maintenance of immunity, can act as inflammatory stimulants that may induce/maintain the inflammatory reaction leading to severe side-effects.
As part of a larger study evaluating the efficacy of various mono- and multi-component furunculosis vaccines, this study was undertaken to examine sequential gross and histomorphological changes at the injection site of Atlantic salmon following i.p. injection with oil adjuvanted vaccines. The pyloric caeca, head kidney and spleen were examined at 3, 6 and 12 months following vaccination. The side-effect profile and the specific growth rate of individual fish were also monitored at the same time points.
Section snippets
Vaccination trial
The materials used in this study were collected as part of a vaccination trial conducted by Alpharma AS at EWOS Innovation facilities in Norway from January 2001 to January 2002. Processing and examination of the samples were done at the Norwegian School of Veterinary Science in Oslo, Norway.
Fish
About 4000 Atlantic salmon pre-smolts, weighing about 70 g each and reared in fresh water were transferred to EWOS Innovation experimental facility in Dirdal. The fish were a Norwegian Salmon Breeders'
Intra-abdominal lesions
All 180 fish sampled from groups A to F exhibited macroscopical lesions. No lesions were observed in the control fish (group G). Of the lesions observed, 98.9% were located around the pyloric caeca and spleen (injection site), 78.3% caudally, along the descending intestine near the urinary bladder, while 56.9% exhibited dorso-anterior lesions near the septum transversum and oesophagus. The lesions comprised of adhesions in the form of soft strands of fibrous tissue between adjacent organs
Discussion
The results presented in this paper suggest that persistent antigens of oil-based vaccines are associated with stimulation and maintenance of inflammatory reaction at the injection site of Atlantic salmon leading to adverse side-effects. In all vaccinated groups, persistent antigens were consistently observed with active inflammation that was characterised by the predominant presence of macrophages and lymphocytes as well as varying numbers of polymorphonuclear cells throughout the observation
Acknowledgements
Financial support for this study was obtained from the European Commission (CT-1999-00799).
References (30)
- et al.
Immunocompetence and duration of immunity against Vibrio salmonicida and Aeromonas salmonicida after vaccination of Atlantic salmon (Salmo salar L.) at low and high temperatures
Fish & Shellfish Immunology
(1997) - et al.
Protection, immune responses and side effects in Atlantic salmon (Salmo salar L.) vaccinated against furunculosis by different procedures
Fish & Shellfish Immunology
(1996) - et al.
Experimental studies on the efficacy and side effects of intraperitoneal vaccination of Atlantic salmon (Salmo salar L.) against furunculosis
Fish & Shell fish Immunology
(1996) - et al.
Adjuvants designed for veterinary and human vaccines
Vaccine
(2001) - et al.
Placebo-controlled trial of varicella vaccine given with or after measles-mumps-rubella vaccine
The Journal of Pediatrics
(1989) - et al.
The effect of vaccination and vaccine components upon short-term growth and feed conversion efficiency in rainbow trout
Aquaculture
(1999) Vaccination of Atlantic salmon (Salmo salar L.) against cold-water vibriosis-duration of protection and effect on growth rate
Aquaculture
(1991)- et al.
Effects of potassium sulphate (alum) used in Aeromonas salmonicida bacterin on Atlantic salmon, Salmo salar L
Journal of Fish Diseases
(1995) - et al.
The effects of the use of potassium alum adjuvant in vaccines against vibriosis in rainbow trout, Salmo gairdneri Richardson
Journal of Fish Diseases
(1984) - et al.
Pathology of Atlantic salmon Salmo salar intraperitoneally immunised with oil adjuvanted vaccine. A case report
Diseases of Aquatic Organisms
(1997)
Retention of furunculosis vaccine components in Atlantic salmon, Salmo salar L., following different routes of vaccine administration
Journal of Fish Diseases
Practical statistics for medical research
Applied regression analysis and other multivariable methods
Rate of disappearance of diphtheria toxoid injected into rabbits and guinea pigs: toxoid precipitated with alum
Journal of Pathology and Bacteriology
The application of adjuvants to veterinary medicine
Veterinary Bulletin
Cited by (107)
A compound ginseng stem leaf saponins and aluminium adjuvant enhances the potency of inactivated Aeromonas salmonicida vaccine in turbot
2022, Fish and Shellfish Immunology